287 related articles for article (PubMed ID: 19757056)
21. Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic-pathologic correlation in an animal study.
Li S; Chen F; Shen L; Zeng Q; Wu P
J Transl Med; 2016 Aug; 14(1):238. PubMed ID: 27495906
[TBL] [Abstract][Full Text] [Related]
22. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
23. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
[TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
25. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
[TBL] [Abstract][Full Text] [Related]
26. Irreversible electroporation: an in vivo study with dorsal skin fold chamber.
Qin Z; Jiang J; Long G; Lindgren B; Bischof JC
Ann Biomed Eng; 2013 Mar; 41(3):619-29. PubMed ID: 23180025
[TBL] [Abstract][Full Text] [Related]
27. Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation.
Zupanic A; Kos B; Miklavcic D
Phys Med Biol; 2012 Sep; 57(17):5425-40. PubMed ID: 22864181
[TBL] [Abstract][Full Text] [Related]
28. Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro.
Yang Y; Moser MAJ; Zhang E; Zhang W; Zhang B
PLoS One; 2018; 13(4):e0195561. PubMed ID: 29694357
[TBL] [Abstract][Full Text] [Related]
29. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning.
Neal RE; Garcia PA; Robertson JL; Davalos RV
IEEE Trans Biomed Eng; 2012 Apr; 59(4):1076-85. PubMed ID: 22231669
[TBL] [Abstract][Full Text] [Related]
30. Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
Zhang W; Wang W; Chai W; Luo X; Li J; Shi J; Bi L; Niu L
PLoS One; 2017; 12(7):e0181555. PubMed ID: 28732031
[TBL] [Abstract][Full Text] [Related]
31. Irreversible electroporation: implications for prostate ablation.
Onik G; Mikus P; Rubinsky B
Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
[TBL] [Abstract][Full Text] [Related]
32. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
33. Changes of apoptosis in tumor tissues with time after irreversible electroporation.
Kim HB; Sung CK; Baik KY; Moon KW; Kim HS; Yi JH; Jung JH; Moon MH; Choi OK
Biochem Biophys Res Commun; 2013 Jun; 435(4):651-6. PubMed ID: 23688425
[TBL] [Abstract][Full Text] [Related]
34. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
35. Cancer cells ablation with irreversible electroporation.
Miller L; Leor J; Rubinsky B
Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
[TBL] [Abstract][Full Text] [Related]
36. Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells
Lindelauf KHK; Baragona M; Baumann M; Maessen RTH; Ritter A
Technol Cancer Res Treat; 2023; 22():15330338221136694. PubMed ID: 36600679
[TBL] [Abstract][Full Text] [Related]
37. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation.
Sahakian AV; Al-Angari HM; Adeyanju OO
IEEE Trans Biomed Eng; 2012 Mar; 59(3):604-7. PubMed ID: 22194234
[TBL] [Abstract][Full Text] [Related]
38. Pulse timing during irreversible electroporation achieves enhanced destruction in a hindlimb model of cancer.
Jiang C; Shao Q; Bischof J
Ann Biomed Eng; 2015 Apr; 43(4):887-95. PubMed ID: 25269611
[TBL] [Abstract][Full Text] [Related]
39. Intravascular irreversible electroporation: theoretical and experimental feasibility study.
Maor E; Ivorra A; Rubinsky B
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2051-4. PubMed ID: 19163098
[TBL] [Abstract][Full Text] [Related]
40. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment.
Neal RE; Rossmeisl JH; D'Alfonso V; Robertson JL; Garcia PA; Elankumaran S; Davalos RV
Ann Biomed Eng; 2014 Mar; 42(3):475-87. PubMed ID: 24165928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
